Detail of > 60-93-5
- MSDS Download

- CAS Number:
- 60-93-5
- Name:
Quinine dihydrochloride
- Formula:
- C20H26Cl2N2O2
- Molecular Structure:

- Synonyms:
- Cinchonan-9-ol,6'-methoxy-, dihydrochloride, (8a,9R)- (9CI);Quinine, dihydrochloride (8CI);(-)-Quinine dihydrochloride;Acid quinine hydrochloride;Quinine bimuriate;Cinchonan-9-ol,6'-methoxy-, hydrochloride (1:2), (8a,9R)-;
- Molecular Weight:
- 397.34
- EINECS:
- 200-493-4
- Boiling Point:
- 495.9 °C at 760 mmHg
- Flash Point:
- 253.7 °C
- Appearance:
- white solid
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety:
- 26-36Details
Related products
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 349-88-2Benzenesulfonylchloride, 4-fluoro-
- 60-93-5Quinine dihydrochloride
- 33007-83-9Propanoic acid,3-mercapto-, 1,1'-[2-ethyl-2-[(3-mercapto-1-oxopropoxy)methyl]-1,3-propanediyl]ester
- 13908-43-5Urea,N-(2-chloroethyl)-N'-(4-cyanophenyl)-
- 9002-72-6Somatotropin
- 43200-82-45H-Pyrrolo[3,4-b]pyrazine-5,7(6H)-dione,6-(5-chloro-2-pyridinyl)-
- 101-79-1Benzenamine,4-(4-chlorophenoxy)-
- 84788-83-0STU I
- 89365-50-41,3-Benzenedimethanol,4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-
- 136381-85-61H-Indole-1-aceticacid, 2-[[[4-(2-chlorophenyl)-2-thiazolyl]amino]carbonyl]-
- 83-25-02,5-Pyrrolidinedione,1-phenyl-
- 12768-92-2C.I. FluorescentBrightener 113
- 15813-09-94,5-Diiodo-1H-Imidazole
- 10463-37-3Benzeneacetic acid,4-hydroxy-3,5-dinitro-
- 93982-96-8Guanidine,N,N'-diphenyl-, hydrobromide (1:1)
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(23)
India(2)
- Business Type:
- Importer/Exporter(21)Manufacturers(2)
- Certificates:
- ISO(1)Production License(1)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Changes in superhelical density of closed circular deoxyribonucleic acid by intercalation of anti-R-plasmid drugs and primaquine
- Changes in superhelical density of closed circular deoxyribonucleic acid by intercalation of anti-R-plasmid drugs and primaquine. Allison, Richard G.; Hahn, Fred E. (Dep. Mol. Biol., Walter Reed Army Inst. Res., Washington, D. C., USA). Antimicrob. Agents Chemother., 11(2), 251-7 (English) 1977. CODEN: AMACCQ. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) The following compds., which possess anti-R-plasmid activity in decreasing order, were shown to change systematically the superhelical d. of closed circular PM2 DNA in the manner of intercalators: ethidium bromide [1239-45-8], quinacrine HCl [69-05-6], acridine orange [65-61-2], quinine 2HCl [60-93-5], chlorpromazine [69-09-0], chloroquine diphosphate [50-63-5], and methylene blue [61-73-4]. The same effect was caused by the antimalarial drug primaquine diphosphate [63-45-6], which has not been tested for antiplasmid activity.Except for chemicals metioned above, 65-61-2 and 25535-16-4 are also used. .
- The bioavailability of quinine
- The bioavailability of quinine. Garnham, J. C.; Raymond, K.; Shotton, E.; Turner, P. (Sch. Pharm., Univ. London, London, Engl.). J. Trop. Med. Hyg., 79(12), 264-9 (English) 1976. CODEN: JTMHA9. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) In vitro dissoln. studies of quinine(I) [130-95-0] frm plain tablets of 3 of its salts suggested a correlation between the soly. of the salts and their dissoln. profiles. I di-HCl [60-93-5] dissolved faster than I bisulfate [549-56-4], which in turn dissolved faster than I sulfate [804-63-7]. Sugar-coated tablets of the salts gave the same trend, but there was a long in vitro lag time for the appearance of I in the dialysis cell used to study the dissoln., due to a delayed disintergration of the tablets. This delay was paralled by a delayed appearance of I in plasma after administration of the coated tablets to persons. The absorption lag time is apparently a function of the formulation and the soly. of the drug. The pharmacokinetics of the plain tablets showed that the di-HCl was the drug of choice because of its rapid appearance in the blood. The com. brand of sugar-coated di-HCl tablets, however, gave low availability when compared with the plain tablets or capsules of the same salt.
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

